Aclaris: 3Q Earnings Snapshot
WAYNE, Pa. (AP) _ Aclaris Therapeutics Inc. (ACRS) on Wednesday reported a loss of $10.7 million in its third quarter.
The Wayne, Pennsylvania-based company said it had a loss of 25 cents per share.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 29 cents per share.
The specialty pharmaceutical company posted revenue of $1.4 million in the period, which met Street forecasts.
The company's shares closed at $3.71. A year ago, they were trading at $1.81.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACRS at https://www.zacks.com/ap/ACRS